Elizabeth J Stewart, 49Lynnwood, WA

6440445, Aug 27, 2002

Feb 20, 1998

09/011969

Romana A. Nowak - West Roxbury MA
Elizabeth A. Stewart - Cambridge MA

Brigham Womens Hospital - Boston MA

A61F 202

424423, 424426

The invention provides methods for treating abnormal uterine bleeding via application of compounds that block uterine stromal cell response to angiogenic growth factors by interfering with the growth factors themselves, by blocking receptors in the uterine epithelial or stromal cells to those growth factors, and/or by inhibiting other receptors to those growth factors. The compounds include interferons, particularly type I interferons, pirfenidone, heparin, heparin-like polyaromatic anionic compounds, heparin-sulfate-based compounds, secreted or soluble FGF receptors, and/or RGD-peptide. The angiogenic growth factors to which response is blocked include basic fibroblast growth factor (bFGF), FGF receptors (FGFR), acidic fibroblast growth factor (aFGF), transforming growth factor (TGF-), platelet-derived growth factor (PDGF), heparin binding epidermal growth factor (HBEGF), vascular endothelial growth factor (VEGF), parathyroid hormone-related protein (PTHrP) and/or prolactin. The methods contemplate introducing the aforementioned response-blocking compounds into the body of a patient either systemically, e. g. , via injection or implant, or locally to the uterus, e. g.

2003012, Jul 10, 2003

Oct 29, 2002

10/284753

Tod Klinger - San Carlos CA, US
Elizabeth Stewart - Mill Creek WA, US
Henry Yue - Sunnyvale CA, US
Mariah Baughn - San Leandro CA, US

Incyte Genomics, Inc. - Palo Alto CA

G01N033/53
G01N033/574
C12N009/22
C12M001/34

435/007100, 435/007230, 435/199000, 435/287200

The invention provides GTPase activating proteins, their encoding cDNAs, and antibodies that specifically bind the proteins. The invention also provides for the use of these compositions in the diagnosis, prognosis, treatment and evaluation of progression and treatment of signaling, immune, and cell proliferative disorders, particularly colon cancer.

2004002, Feb 5, 2004

May 27, 2003

10/311764

Janice Au-Young - Brisbane CA, US
Mariah Baughn - San Leandro CA, US
Li Ding - Creve Coeur MO, US
Vicki Elliott - San Jose CA, US
Ameena Gandhi - San Francisco CA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Liam Kearney - San Francisco CA, US
Ernestine Lee - Castro Valley CA, US
Yan Lu - Mountain View CA, US
Danniel Nguyen - San Jose CA, US
Chandra Arvizu - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Roopa Reddy - Fremont CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Elizabeth Stewart - Mill Creek WA, US
Y Tang - San Jose CA, US
Michael Thornton - Oakland CA, US
Catherine Tribouley - San Francisco CA, US
Narinder Chawla - Union City CA, US
Junming Yang - San Jose CA, US
Monique Yao - Carmel IN, US
Henry Yue - Sunnyvale CA, US

C12Q001/68
C07H021/04
C12N009/16
C12P021/02
C12N005/06

435/006000, 435/069100, 435/196000, 435/320100, 435/325000, 536/023200

The invention provides human protein phosphatases (PP) and polynucleotides which identify and encode PP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PP.

2004005, Mar 25, 2004

Jan 28, 2003

10/343357

Vicki Elliott - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Monique Yao - Carmel IN, US
Yu-Mei Wang - Mountain View CA, US
Elizabeth Stewart - Mill Creek WA, US
Ameena Gandhi - San Francisco CA, US
Chandra Arvizu - San Jose CA, US
Ernestine Lee - Castro Valley CA, US
April Hafalia - Santa Clara CA, US
Dyung Aina Lu - San Jose CA, US
Catherine Tribouley - San Francisco CA, US
Jennifer Griffin - Fremont CA, US
Mariah Baughn - San Leandro CA, US
Henry Yue - Sunnyvale CA, US
Bridget Warren - Encinitas CA, US
Daniel Nguyen - San Jose CA, US
Narinder Chawla - Union City CA, US
Liam Kearney - San Francisco CA, US

C12Q001/68
A01K067/00
C12N009/16
C07H021/04
C07K016/40

435/006000, 435/069100, 435/196000, 435/320100, 435/325000, 530/388260, 536/023200, 800/008000

The invention provides human protein phosphatases (PP) and polynucleotides which identify and encode PP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PP.

2004009, May 20, 2004

Jul 2, 2003

10/250613

Dyung Aina Lu - San Jose CA, US
Mariah Baughn - San Leandro CA, US
Monique Yao - Mountain View CA, US
Cynthia Honchell - San Carlos CA, US
Henry Yue - Sunnyvale CA, US
Y Tang - San Jose CA, US
Bridget Warren - San Marcos CA, US
Brendan Duggan - Sunnyvale CA, US
Yuming Xu - Mountain View CA, US
Narinder Chawla - Union City CA, US
Jennifer Griffin - Fremont CA, US
Elizabeth Stewart - Mill Creek WA, US
Ameena Gandhi - San Francisco CA, US
Farrah Khan - Des Plaines IL, US
Kavitha Thangavelu - Sunnyvale CA, US
Craig Ison - San Jose CA, US
Yalda Azimzai - Oakland CA, US
April Hafalia - Daly City CA, US
Kimberly Gietzen - San Jose CA, US
Preeti Lal - Santa Clara CA, US
Vicki Elliott - San Jose CA, US

C12Q001/68
A01K067/027
C07K014/47
C07K016/18

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 530/388100, 800/018000

The invention provides human cytoskeleton-associated proteins (CSAP) and polynucleotides which identify and encode CSAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CSAP.

2006021, Sep 28, 2006

Jul 16, 2002

10/484603

Y Tang - San Jose CA, US
Vicki Elliott - San Jose CA, US
Mariah Baughn - Los Angeles CA, US
Henry Yue - Sunnydale CA, US
Aaron Klammer - Boulder CO, US
April Hafalia - Daly City CA, US
Elizabeth Stewart - Mill Creek WA, US
Cynthia Honchell - San Francisco CA, US
Ian Forsythe - Edmonton, CA
Li Ding - Creve Coeur MO, US
Uyen Tran - San Jose CA, US
Jennifer Griffin - Fremont CA, US
Yeganeh Zebarjadian - San Francisco CA, US
Anna Chinn - Sunnydale CA, US
Anne Curtis - Cambridge MA, US
Mark Borowsky - Needham MA, US
Anita Swarnakar - San Francisco CA, US
Neil Burford - Durham CT, US
Wen Luo - San Diego CA, US
Ernestine Lee - Kensington CA, US
Brooke Emerling - Chicago IL, US
Soo Lee - Mountain View CA, US
Junming Yang - San Jose CA, US
Farrah Khan - Canton MI, US
Jayalaxmi Ramkumar - Fremont CA, US
Yan Lu - Mountain View CA, US
Narinder Chawla - Union City CA, US
Brendan Duggan - Sunnydale CA, US
Kimberly Gietzen - San Jose CA, US
Karen Jones - Bollington, GB

C12Q 1/68
G01N 33/574
C07H 21/04
C12P 21/06
C07K 14/705

435006000, 435069100, 435007230, 435320100, 435325000, 530350000, 536023500

Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.

2008026, Oct 30, 2008

Feb 8, 2008

12/028682

Elizabeth Anne Stewart - Mill Creek WA, US

A47K 13/24
B65D 69/00

206223, 4661

The present invention provides devices, kits, and methods for temporarily stopping an automatic flushing assembly on a toilet or urinal from activating. The device may be placed over or on the sensor assembly of the toilet to temporarily block the sensor assembly from sensing the user. In preferred aspects, the device is composed of a material that the user is able to flush down the toilet or urinal such that when the user is finished, the device may be removed and disposed of directly into the toilet or urinal.